
浏览全部资源
扫码关注微信
四川省成都市第六人民医院呼吸内科
纸质出版日期:2008,
扫 描 看 全 文
[1]李伟铭,余阗,郭华,胡铃.雾化吸入利多卡因治疗慢性喘息型支气管炎急性发作的临床疗效[J].重庆医科大学学报,2008(08):1009-1012+1015.
LI Wei-ming, et al. Therapeutic effect of nebulized inhalation of lidocaine in the treatment of acute episode of chronic asthmatic bronchitis[J]. Journal of Chongqing Medical University, 2008,(8):1009-1012.
目的:探索利多卡因在治疗慢性喘息型支气管炎急性发作中的疗效。方法:本文将我院呼吸科2004年8月至2007年7月收治的58例慢性喘息型支气管炎急性发作患者随机分为A、B组。A组为利多卡因雾化组
B组为对照组;两组的其它治疗措施均相同。应用氧气作动力的喷射或雾化器
氧流速为8~10L/min
A组雾化吸入2%利多卡因5m(l100mg)/次治疗
每日3次;B组雾化吸入生理盐水5ml/次
每日3次;连续3d。观察雾化前后心率、呼吸频率和FEV1、PEF以及PaO2及PaCO2变化情况。结果:雾化前后心率、呼吸频率和FEV1、PEF以及PaO2及PaCO2结果显示:利多卡因治疗组患者在雾化吸入30min
1d
3d结束时其心率、呼吸频率较对照组均有显著好转(P<0.05);利多卡因治疗组在雾化吸入30min
1d
3d结束时其FEV1、PEF占预计值百分比较对照组增高明显;PaO2升高、PaCO2降低亦较对照组显著(P<0.05)。两组雾化副反应发生率比较:利多卡因治疗组较对照组高(16.7%与3.6%
P<0.05)
主要为咽部不适、恶心等
均为一过性
且轻微
无1例因副反应而终止治疗。结论:雾化吸入利多卡因治疗慢性喘息性支气管炎急性发作
对缓解喘息症状方面疗效明确
尤其是对β2受体不能耐受的患者是一种的有效治疗手段。
Objective:To search for therapeutic effect of lidocaine in the treatment of acute episode of chronic asthmatic bronchitis.Methods:The 58 cases of patients with acute episode of chronic asthmatic bronchitis admitted to this hospital from August
2004 to July
2007 were divided into group A and group B.Besides group A with lidocaine and group B as control with sodium chloride solution
there were no difference in the other therapeutic measures between group A and Group B.Oxygen was used as the power of spray or aerosolizer
the flow volume of oxygen was 8-10L/min.Group A patients were given 5 milliliters of 2% lidocaine(100mg) by nebulized inhalation three times a day for three days
and Group B patients received 5 milliliters of 0.9% sodium chloride solution by nebulized inhalation three times a day for successive three days.The changes of heart rate
respiratory frequency
forced expiratory volume in one second(FEV1)
peak expiratory flow(PEF)
partial pressure of oxygen in artery(PaO2) and partial pressure of carbon dioxide in artery(PaCO2) were determined in the group A and B before and after the nebulized inhalation therapy.Results:The results of the heart rate
respiratory frequency
FEV1
PEF
PaO2 and PaCO2 before and after the treatment of the nebulized inhalation were showed as follows
improvement of heart rate and respiratory frequency was more significant in the group with the nebulized inhalation treatment of lidocaine than that in the group as control after 30 minutes
one day and three days of therapy(P<0.005).The predicted value percentages of FEV1 and PEF were higher in the group with the nebulized inhalation treatment of lidocaine than that in the group as control after 30 minutes
one day and three days of therapy(P<0.005).The increase of PaO2 and decrease of PaCO2 were more significantly in the group with the nebulized inhalation treatment of lidocaine than that in the group as control after one day and three days of therapy(P<0.05).Compared the adverse reaction of the lidocaine group to the group as control
the incidence of the adverse reaction in the lidocaine group was higher than that in the group as control(16.7% VS 3.6%
P<0.05).The adverse reaction included pharyngeal discomfort
nausea and so on
all of them existing in a transient time and symptoms mild
and no one duo to severe adverse reaction to stop therapy.Conclusion:The therapeutic effect in relieving symptom of asthma of lidocaine by the way of nebulized inhalation in the patients suffering from acute episode of chronic asthmatic bronchitis was identified in this study.This therapy of lidocaine nebulized inhalation was a effective therapeutic tool in the patients with chronic asthmatic bronchitis
especially in the patients who cannot be tolerant to β2 receptor agonist therapy.
慢性喘息型支气管炎雾化吸入利多卡因疗效
Chronic asthmatic bronchitisNebulized inhalationLidolicainetherapeutic effect
0
浏览量
113
下载量
8
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621